Your search for evid returned 4555 results

Strong recommendations made for use of polyethylene glycol, sodium picosulfate, linaclotide, plecanatide, and prucalopride.

Reviewers discussed new and conventional therapies for lupus nephritis and the prospect of precision medicine.

Two draft recommendation statements find lack of evidence for dental screening, preventive interventions in children, adults.

Risk up with amiodarone vs flecainide or sotalol among seniors with atrial fibrillation receiving apixaban or rivaroxaban.

Isaralgagene civaparvovec is a recombinant AAV 2/6 vector carrying the cDNA for human α-galactosidase-A.

A regulatory decision is expected on June 22, 2023.

The phase 3 EMBARK trial involved more than 200 global sites and had 8 years of follow-up.

Extended antibiotics do not reduce infection or reconstruction failure after postmastectomy breast reconstruction.

A regulatory decision is expected in August 2023.

The approval was based on studies that included adults with moderately to severely active Crohn disease who had an inadequate response to or were intolerant of biologic therapy.